Survey of the prognostic elements concerning the efficacy of the activator in Angle Class Ii occlusion
Charron, C.
L' Orthodontie Francaise 60 Pt 2: 685-693
1989
ISSN/ISBN: 0078-6608 PMID: 2490249 Document Number: 336665
Two multiple regression formula allow the prediction of the result for activator treatment concerning Class II occlusion. The accuracy is good on 63% of patients. The first one uses the incisal oberbite and overjet, and the height of the ramus; the other one uses the motivation of the patient before the beginning of treatment and the height of the ramus.
Document emailed within 1 workday
Related Documents
Faccioni, P.; De Santis, D.; Luciano, U.; Pancera, P.; Sinigaglia, S.; Iurlaro, A.; Bertossi, D.; Lucchese, A.; Manuelli, M.; Maestrini, S.; Kumar, N.; Zotti, F.; Donadello, D.; Ricciardi, G.; Albanese, M.; Cicalese, M.P. 2019: Efficacy of the Andresen activator before peak growth in class Ii patients Journal of Biological Regulators and Homeostatic Agents 33(1 Part 1): 1-7Zhou, L.; Zhou, L.; Wu, H.; Li, J. 2010: Preliminary investigation about incisor inclination and dental compensation of normal occlusion and angle's class II division 1 malocclusion with different growth patterns Hua Xi Kou Qiang Yi Xue Za Zhi 28(5): 492-494
Halimi, A.; Azeroual, M.F.; Abouqal, R.; Zaoui, F. 2011: A comparative study of the transverse dimensions of the dental arches between Class i dental occlusion and Class II1 and Class II2 malocclusions Odonto-Stomatologie Tropicale 34(136): 47-52
Charreau, B.; Coupel, S.; Boulday, G.; Soulillou, J.P. 2000: Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene Transplantation 70(2): 354-361
Puzanowska-Tarasiewicz, H.; Kuźmicka, L.ła.; Tarasiewicz, M.ła. 2009: Biological function of some elements and their compounds. III. Zinc--component and activator of enzymes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 27(161): 419-422
Andrik, P. 1988: Contribution to the treatment of the Class II/1 by means of the activator-headgear combination Stomatologie der DDR 38(6): 382-386
Von Romatowski, H.J.; Henze, T.; Tebbe, U. 1988: Recanalization of basilar artery occlusion with tissue-type plasminogen activator Deutsche Medizinische Wochenschrift 113(15): 616
Zhang, X-ge.; Yang, F.; Chen, L.; Chen, S.; Chen, Y-xi. 2010: Angle's class II malocclusion: a report of seven cases in one family Hua Xi Kou Qiang Yi Xue Za Zhi 28(2): 219-220
Vaugeois, M.; Hadjean, E.; Horn, A. 1980: Preoperative orthodontic treatment of Angle's class II, division 1 L' Orthodontie Francaise 51: 125-131
Li, S.; Xu, T.-M.; Lin, J.-X. 2009: Analysis of treatment templates of Angle's Class IIi malocclusion patients Hua Xi Kou Qiang Yi Xue Za Zhi 27(6): 637-641
Wilkes, N.P.; Magee, M.; Hoschl, R.; Nelson, G.I. 1990: Late (one month) reversible ischaemia after primary coronary occlusion treated with recombinant tissue plasminogen activator (rTPA) Australian and New Zealand Journal of Medicine 20(2): 149-153
Ronquillo, H.I.; Guay, J.; Tallents, R.H.; Katzberg, R.; Murphy, W.; Proskin, H. 1988: Comparison of internal derangements with condyle-fossa relationships, horizontal and vertical overlap, and Angle Class Journal of Craniomandibular Disorders 2(3): 137-140
Delarue, F.; Hertig, A.; Alberti, C.; Vigneau, C.; Ammor, M.; Berrou, J.; Akposso, K.; Peraldi, M.N.; Rondeau, E.; Sraer, J.D. 2001: Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys Transplantation 72(7): 1256-1261
Mühlberg, G.; Kahlert, G. 1970: Biostatistical study of the influence of the type i function regulators of Frankel and of the FKO activator on the angle formed by the palatal plane and the mandibular plane in the lateral teleroentgenologic picture Deutsche Stomatologie 20(6): 401-408
Taponeco, F.; Curcio, C.; Giuntini, A.; Nardini, V.; Fornaciari, G.; Artini, P.G.; D'Ambrogio, G.; Genazzani, A.R. 2001: Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer Journal of Experimental and Clinical Cancer Research: Cr 20(2): 239-246
Le Meur, Y. 2018: Polycystic kidney disease: diagnosis and progressive profile, prognostic elements La Revue du Praticien 68(5): 559-563
Vitiello, A.; Sherman, L.A. 1983: Recognition of influenza-infected cells by cytolytic T lymphocyte clones: determinant selection by class I restriction elements Journal of Immunology 131(4): 1635-1640
Agresta, F.; Michelet, I.; Boni, V.; Tonietto, G. 1998: Thrombolysis with i.v. recombinant human tissue-type plasminogen activator in patients with bypass graft occlusion: a good adjunctive therapeutic mode (preliminary and case reports) Journal of Cardiovascular Surgery 39(5): 551-555
Greco, M.; Fichera, G.; Caltabiano, M.; Barbato, E.; Leonardi, R. 2010: Short-term effects of the activator in skeletal class II division 1 patients with different vertical skeletal pattern. A retrospective study Minerva Stomatologica 59(3): 61-74
Ghoubril, J.V.; Abou Obeid, F.M. 2012: Three-dimensional assessment of facial bone cavities in Class i occlusion with normodivergent skeletal pattern Odonto-Stomatologie Tropicale 35(140): 21-30